Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Abaloparatide |
| Trade Name | Tymlos |
| Synonyms | BA058|BA-058|BIM44058|BIM-44058 |
| Drug Descriptions |
Abaloparatide (Tymlos) is a peptide analog of human parathyroid hormone-related protein (PTHrP), which stimulates bone formation and potentially increases bone mineral density (PMID: 25393645, PMID: 29260289). Abaloparatide (Tymlos) is FDA approved for osteoporosis (FDA.gov). |
| DrugClasses | |
| CAS Registry Number | 247062-33-5 |
| NCIT ID | C158818 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abaloparatide | Abaloparatide | 0 | 0 |
| Abaloparatide + Bevacizumab | Abaloparatide Bevacizumab | 0 | 1 |